Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 10631-10640 of 11953

Edit search filters
  1. Patient Outcomes after Intralesional Injections of Collagenase Clostridium Histolyticum for Peyronie's Disease

    Scottsdale/Phoenix, AZ

  2. Sleep Apnea and HCM

    Rochester, MN

  3. Recovery of Left Ventricular Systolic Function and Atrial Fibrillation Recurrence after Restoration of Sinus Rhythm in Patients with Atrial Fibrillation

    Rochester, MN

  4. A Study of Vascular Dysfunction in Polycystic Kidney Disease (PKD)

    Rochester, MN

  5. COVID-19 (Coronavirus) Pandemic on Health and Healthcare

    Rochester, MN

  6. Patient Perceptions of the Impact of Unproven Stem Cell Corrections

    Rochester, MN

  7. Left Ventricular Remodeling and Echocardiographic Predictors of Mortality in Severe Aortic Stenosis

    Rochester, MN

  8. Ventricular Arrhythmias and Premature Ventricular Contraction in Patients with Prosthetic Valve: Electrophysiological Characteristics, Ablation Technique, Outcomes And Complications

    Rochester, MN

  9. Prognostic Risk Evaluation for Hypereosinophilic Syndrome (HES) and Idiopathic Hypereosinophilia (IHE) and the Role of Next-generation Sequencing

    Rochester, MN

  10. A Study to Find the Risk Factors for Death in Patients with Severe Left Ventricular Systolic Dysfunction Undergoing Coronary Artery Bypass Grafting

    Rochester, MN

.

Mayo Clinic Footer